Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta cir. bras ; 33(2): 175-184, Feb. 2018. graf
Artigo em Inglês | LILACS | ID: biblio-886262

RESUMO

Abstract Purpose: To investigate the effects of aquaporin 4 (AQP4) and inward rectifier potassium channel 4.1 (Kir4.1) on medullospinal edema after treatment with methylprednisolone (MP) to suppress acute spinal cord injury (ASCI) in rats. Methods: Sprague Dawley rats were randomly divided into control, sham, ASCI, and MP-treated ASCI groups. After the induction of ASCI, we injected 30 mg/kg MP via the tail vein at various time points. The Tarlov scoring method was applied to evaluate neurological symptoms, and the wet-dry weights method was applied to measure the water content of the spinal cord. Results: The motor function score of the ASCI group was significantly lower than that of the sham group, and the spinal water content was significantly increased. In addition, the levels of AQP4 and Kir4.1 were significantly increased, as was their degree of coexpression. Compared with that in the ASCI group, the motor function score and the water content were significantly increased in the MP group; in addition, the expression and coexpression of AQP4 and Kir4.1 were significantly reduced. Conclusion: Methylprednisolone inhibited medullospinal edema in rats with acute spinal cord injury, possibly by reducing the coexpression of aquaporin 4 and Kir4.1 in medullospinal tissues.


Assuntos
Animais , Masculino , Ratos , Doenças da Medula Espinal/tratamento farmacológico , Traumatismos da Medula Espinal/tratamento farmacológico , Metilprednisolona/farmacologia , Canais de Potássio Corretores do Fluxo de Internalização/metabolismo , Edema/tratamento farmacológico , Aquaporina 4/metabolismo , Glucocorticoides/farmacologia , Medula Espinal/citologia , Medula Espinal/efeitos dos fármacos , Doenças da Medula Espinal/metabolismo , Traumatismos da Medula Espinal/induzido quimicamente , Metilprednisolona/uso terapêutico , Distribuição Aleatória , Doença Aguda , Imunofluorescência , Ratos Sprague-Dawley , Canais de Potássio Corretores do Fluxo de Internalização/uso terapêutico , Modelos Animais de Doenças , Edema/metabolismo , Aquaporina 4/uso terapêutico , Glucocorticoides/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA